Document ID: chunk:federal_register_of_legislation:F2019L01093:reg:9:p3
Version: federal_register_of_legislation:F2019L01093
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 9262–10717

granuloma; and
                (f)        necrotising otitis externa.
Note 2: exostosis of the external auditory canal is defined in the Schedule 1 – Dictionary.
(23)      having chronic otitis media, involving the middle ear of the affected side, at the time of the clinical worsening of conductive hearing loss;
Note: chronic otitis media is defined in the Schedule 1 - Dictionary.
(24)      having:
(a)          a benign or malignant neoplasm; or
(b)          other mass lesion;
involving the middle ear of the affected side, at the time of the clinical worsening of conductive hearing loss;
            Note:  Examples of neoplasms or mass lesions involving the middle ear include, but are not limited to:
               (a)         cholesteatoma;
               (b)       granuloma; and
               (c)         neuroendocrine adenoma.
(25)      having a disease from the specified list of autoimmune diseases, at the time of the clinical worsening of conductive hearing loss;
Note: specified list of autoimmune diseases is defined in the Schedule 1 – Dictionary.
(26)      undergoing a course of therapeutic radiation for cancer, where the conductive hearing apparatus of the affected side was in the field of radiation, before the clinical worsening of conductive hearing loss;
Note: conductive hearing apparatus is defined in the Schedule 1 – Dictionary.
(27)      inability to obtain appropriate clinical management for conductive hearing loss.